Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Rare but Recurrent ROS1 Fusions Resulting From Chromosome 6q22 Microdeletions are Targetable Oncogenes in Glioma.

Davare MA, Henderson JJ, Agarwal A, Wagner JP, Iyer SR, Shah N, Woltjer R, Somwar R, Gilheeney SW, DeCarvalo A, Mikkelson T, Van Meir EG, Ladanyi M, Druker BJ.

Clin Cancer Res. 2018 Dec 15;24(24):6471-6482. doi: 10.1158/1078-0432.CCR-18-1052. Epub 2018 Aug 31.

PMID:
30171048
2.

Patterns of relapse for children with localized intracranial ependymoma.

De B, Khakoo Y, Souweidane MM, Dunkel IJ, Patel SH, Gilheeney SW, De Braganca KC, Karajannis MA, Wolden SL.

J Neurooncol. 2018 Jun;138(2):435-445. doi: 10.1007/s11060-018-2815-7. Epub 2018 Mar 6.

3.

Long-term outcomes of adult medulloblastoma patients treated with radiotherapy.

De B, Beal K, De Braganca KC, Souweidane MM, Dunkel IJ, Khakoo Y, Gilheeney SW, DeAngelis LM, Menzel P, Patel SH, Wolden SL.

J Neurooncol. 2018 Jan;136(1):95-104. doi: 10.1007/s11060-017-2627-1. Epub 2017 Oct 10.

4.

A phase II study of radioimmunotherapy with intraventricular 131 I-3F8 for medulloblastoma.

Kramer K, Pandit-Taskar N, Humm JL, Zanzonico PB, Haque S, Dunkel IJ, Wolden SL, Donzelli M, Goldman DA, Lewis JS, Lyashchenko SK, Khakoo Y, Carrasquillo JA, Souweidane MM, Greenfield JP, Lyden D, De Braganca KD, Gilheeney SW, Larson SM, Cheung NV.

Pediatr Blood Cancer. 2018 Jan;65(1). doi: 10.1002/pbc.26754. Epub 2017 Sep 22.

5.

Reduced-volume radiotherapy for patients with localized intracranial nongerminoma germ cell tumors.

De B, Cahlon O, Dunkel IJ, De Braganca KC, Khakoo Y, Gilheeney SW, Souweidane MM, Wolden SL.

J Neurooncol. 2017 Sep;134(2):349-356. doi: 10.1007/s11060-017-2532-7. Epub 2017 Jun 28.

6.

A phase I study of single-agent perifosine for recurrent or refractory pediatric CNS and solid tumors.

Becher OJ, Millard NE, Modak S, Kushner BH, Haque S, Spasojevic I, Trippett TM, Gilheeney SW, Khakoo Y, Lyden DC, De Braganca KC, Kolesar JM, Huse JT, Kramer K, Cheung NV, Dunkel IJ.

PLoS One. 2017 Jun 5;12(6):e0178593. doi: 10.1371/journal.pone.0178593. eCollection 2017.

7.

Retrospective Evaluation of Palifermin Use in Nonhematopoietic Stem Cell Transplant Pediatric Patients.

Liu D, Seyboth B, Mathew S, Gilheeney SW, Chou AJ, Drill E, Kobos R.

J Pediatr Hematol Oncol. 2017 May;39(4):e177-e182. doi: 10.1097/MPH.0000000000000791.

PMID:
28234746
8.

A phase I study of perifosine with temsirolimus for recurrent pediatric solid tumors.

Becher OJ, Gilheeney SW, Khakoo Y, Lyden DC, Haque S, De Braganca KC, Kolesar JM, Huse JT, Modak S, Wexler LH, Kramer K, Spasojevic I, Dunkel IJ.

Pediatr Blood Cancer. 2017 Jul;64(7). doi: 10.1002/pbc.26409. Epub 2016 Dec 30.

PMID:
28035748
9.

Intensity-Modulated Radiation Therapy With Dose Painting: A Brain-Sparing Technique for Intracranial Germ Cell Tumors.

Yang JC, Terezakis SA, Dunkel IJ, Gilheeney SW, Wolden SL.

Pediatr Blood Cancer. 2016 Apr;63(4):646-51. doi: 10.1002/pbc.25867. Epub 2015 Dec 24.

10.

Extraneural metastases of medulloblastoma: desmoplastic variants may have prolonged survival.

Young RJ, Khakoo Y, Yhu S, Wolden S, De Braganca KC, Gilheeney SW, Dunkel IJ.

Pediatr Blood Cancer. 2015 Apr;62(4):611-5. doi: 10.1002/pbc.25354. Epub 2014 Dec 11.

PMID:
25504865
11.

A case of mannitol hypersensitivity.

Lightner DD, De Braganca K, Gilheeney SW, Khakoo Y, Kramer K, Balas M.

J Pediatr Hematol Oncol. 2013 Oct;35(7):e274-5. doi: 10.1097/MPH.0b013e31828d5b3e.

PMID:
24060838
12.

Diffusion-weighted imaging to assess treatment response in a child with trilateral retinoblastoma.

Bonci GA, Rosenblum MK, Gilheeney SW, Dunkel IJ, Holodny AI.

Pediatr Radiol. 2013 Sep;43(9):1231-4. doi: 10.1007/s00247-013-2662-9. Epub 2013 Mar 12.

PMID:
23478798
13.

Collision in the inferior olive: hypertrophic olivary degeneration complicated by radiation necrosis in brainstem primitive neuroendocrine tumor.

Litkowski P, Young RJ, Wolden SL, Souweidane MM, Haque S, Gilheeney SW.

Clin Imaging. 2012 Jul-Aug;36(4):371-374. doi: 10.1016/j.clinimag.2011.09.014. Epub 2012 Jun 8.

14.

Differences in molecular genetics between pediatric and adult malignant astrocytomas: age matters.

Gilheeney SW, Kieran MW.

Future Oncol. 2012 May;8(5):549-58. doi: 10.2217/fon.12.51. Review.

PMID:
22646770
15.

Disease control and ototoxicity using intensity-modulated radiation therapy tumor-bed boost for medulloblastoma.

Polkinghorn WR, Dunkel IJ, Souweidane MM, Khakoo Y, Lyden DC, Gilheeney SW, Becher OJ, Budnick AS, Wolden SL.

Int J Radiat Oncol Biol Phys. 2011 Nov 1;81(3):e15-20. doi: 10.1016/j.ijrobp.2010.11.081. Epub 2011 Apr 12.

PMID:
21481547
16.

Novel use of zolpidem in cerebellar mutism syndrome.

Shyu C, Burke K, Souweidane MM, Dunkel IJ, Gilheeney SW, Gershon T, Khakoo Y.

J Pediatr Hematol Oncol. 2011 Mar;33(2):148-9. doi: 10.1097/MPH.0b013e3182053a1a.

PMID:
21285896
17.

Thiotepa/topotecan/carboplatin with autologous stem cell rescue in recurrent/refractory/poor prognosis pediatric malignancies of the central nervous system.

Gilheeney SW, Khakoo Y, Souweidane M, Wolden S, Boulad F, Dunkel IJ.

Pediatr Blood Cancer. 2010 Apr;54(4):591-5. doi: 10.1002/pbc.22347.

PMID:
19998470
18.

Outcome of pediatric pineoblastoma after surgery, radiation and chemotherapy.

Gilheeney SW, Saad A, Chi S, Turner C, Ullrich NJ, Goumnerova L, Scott RM, Marcus K, Lehman L, De Girolami U, Kieran MW.

J Neurooncol. 2008 Aug;89(1):89-95. doi: 10.1007/s11060-008-9589-2. Epub 2008 Apr 16.

PMID:
18415046
19.

A phase II trial of thalidomide and cyclophosphamide in patients with recurrent or refractory pediatric malignancies.

Gilheeney SW, Lyden DC, Sgouros S, Antunes N, Gerald W, Kramer K, Lis E, Meyers P, Rosen N, Thaler HT, Trippett T, Wexler L, Dunkel IJ.

Pediatr Blood Cancer. 2007 Sep;49(3):261-5.

PMID:
16972243

Supplemental Content

Loading ...
Support Center